Revolution Medicines, Inc. Common Stock
RVMDNASDAQHealthcare · Biological Products, (no Diagnostic Substances)
Market cap
$30.97B
Employees
883
Exchange
NASDAQ
Headquarters
REDWOOD CITY, CA
About Revolution Medicines, Inc. Common Stock
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.
Industry
Biological Products, (no Diagnostic Substances)
Sector
Healthcare
Country
US
Website
www.revmed.comRVMD news
Cancer centers across the United States are competing to gain access to Revolution Medicines' newly developed pancreatic cancer treatment. The breakthrough therapy represents a significant advancement in oncology, with medical institutions prioritizing patient enrollment in treatment programs. This high demand underscores the drug's potential commercial value and therapeutic significance in addressing a historically difficult-to-treat cancer type.
Benzinga · May 15, 2026